MyFinsight
Home
About
Contact
lyel: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, LYEL has $407,965K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
407,965
385,453
Total stockholders equity
329,121
298,923
Total liabilities and stockholders equity
407,965
385,453
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$8,577K
Marketable securities
$196,049K
Cash and cash
equivalents
$123,575K
Other non-current
assets
$2,545K
Operating lease
right-of-use assets
$19,912K
Property and equipment,
net
$36,722K
Other investments
$19,000K
Restricted cash
$1,585K
Total current assets
$328,201K
Total assets
$407,965K
Total liabilities and
stockholders equity
$407,965K
Total stockholders
equity
$329,121K
Total liabilities
$78,844K
Accumulated deficit
-$1,478,831K
Accumulated other
comprehensive income
$201K
Additional paid-in capital
$1,807,749K
Other non-current
liabilities
$2,681K
Operating lease
liabilities, non-current
$44,285K
Total current
liabilities
$31,878K
Common stock, value,
issued
$2K
Accrued liabilities and
other current...
$29,310K
Accounts payable
$2,568K
Subscribe for Financial Insights
Lyell Immunopharma, Inc. (LYEL)
Lyell Immunopharma, Inc. (LYEL)